All news

31/10/2014

ONE Study: new advance for patients with transplanted organs

ONE Study, a research program of the CESTI University Hospital Institute, applies the innovative concept of cell therapy in the field of organ transplantation. A clinical trial based on this therapy and which aims at limiting the side effects of anti -rejection treatments will start in Nantes by the end of the year.

28/10/2014

New member: Oncotherex, development of personalized medicine in breast and ovarian cancer

Oncotherex

Oncotherex offers innovative technology to improve drug development and personalized treatment of patients with breast cancer (1.5 million patients worldwide, + 50% by 2030) and ovarian cancer (240,000 patients worldwide, + 43% by 2030). Oncotherex is incubated by Atlanpole and accompanied by Angers Technopole.

27/10/2014

New member: TrisKem International, manufacturer of radionuclides extraction reactives

TrisKem International

Triskem International manufactures and develops radionuclides separation resins used in the fields of radiation protection and nuclear medicine.

24/10/2014

VitamFero successfully secures its third round of financing

Logo Vitamfero

VitamFero is a company developing novel anti-infective (notably anti-parasitics) prophylactic applications in animal health. It has just secured an icrease in new capital increase to the sum of €2,7 million with Go Capital (through the West Ventures II Fund), Pradeyrol Développement and Business Angels, which is affiliated with Val de France Angels, in partnership with the original shareholders. VitamFero is a member of Atlanpole Biotherapies competitive cluster.

24/10/2014

IN2LifeSciences : First preliminary results after clinical study

logo in2lifesciences

NEOSTEO is a French innovative startup specialized in the development, production and marketing of advanced implant solutions aimed at simplifying orthopedic and trauma surgery. NEOSTEO offers a smart implant line of Osteotomy Solutions to treat knee arthrosis deformities. The SME wanted to collaborate through the IN2LifeSciences network, to evaluate its “FlexitSystem” solution by measuring stability and strength of the high tibial osteotomy.

22/10/2014

New member: BE Vaccines, Centre of Excellence of Biological E company for the development of viral vaccines

BE Vaccines

BE Vaccines is the French subsidiary of the Indian company Biological E. BE Vaccines’s mission is to develop processes for production of viral vaccines and produce material for preclinical and clinical testing. The company is based in Saint-Herblain (44 ) and has thirty employees.

22/10/2014

Genotrace Project : Real time in vitro evaluation of the carcinogenic potential of contaminants

Genotrace

[Press Release] The Genotrace project, combining targeted research and technology transfer1, aims at delivering an innovative test to improve the safety of chemical products, drugs, human and animal food and the environment. The project consortium is led by INRA (French National Institute for Agricultural Research) and includes CNRS (French National Center for Scientific Research), the University Toulouse III – Paul Sabatier and the company Biopredic International. The Genotrace project has just received the support of the French National Research Agency (ANR) for three years.

15/10/2014

Horama biotechnology company raises € 450k

Horama

Since its foundation in March 2014, Horama develops solutions for gene therapy to target rare genetic diseases in ophthalmology. The company has announced an appeal for funding for € 450,000 which will enable it to prepare for the launch of its first product for the treatment of retinitis pigmentosa .

29/09/2014

Cesti IHU: tangible results within the last two years

Business creations, patents, recruitment ... The European Transplantation and Immunotherapy Science Center shows concrete results for two years. It is now carrying about twenty research projects of which Atlanpole Biotherapies will offer a monthly decoding. Next month, you will find out about the "One Study" project, a clinical trial about cellular immunotherapy in transplantation in man.

10/06/2014

Bio Business Week : "4 days combining concrete exercises on their research and expert coaching"

From 10 to 13 June, a dozen foreign students, selected on the basis of their motivation to put a value on their research, took part in an accelerated training in Nantes. They were led by professionals, to be enabled to create their start-up business. This multicultural group (from England, Eastern Europe, Sweden, China ...) working in the field of biotechnology, studied the themes of intellectual property, finance and funding sources, and finally produced a trial presentation.

10/03/2014

A new member: Dentaurum Ceramics, research and ceramic manufacturing center

Dentaurum Ceramics is the ceramic research and manufacturing center of the Group Dentaurum GmbH and Co.KG, one of the European leaders in orthodontics and dentures. Established since 1994, in France near Angers, Dentaurum Ceramics develops and produces the Dentaurum group’s entire range of dental ceramics.

17/02/2014

Cédric Le May was awarded the Daniel Steinberg prize of the best scientific publication

Crédits photo : Presse Océan - Olivier Lanrivain

Researcher at the thorax Institute, Cédric Le May was awarded the Daniel Steinberg prize of the best 2013 scientific publication.